Next Article in Journal
Investigation of the Anti-Inflammatory Properties of Bioactive Compounds from Olea europaea: In Silico Evaluation of Cyclooxygenase Enzyme Inhibition and Pharmacokinetic Profiling
Previous Article in Journal
Characterization of WO3/Silicone Rubber Composites for Hydrogen-Sensitive Gasochromic Application
Previous Article in Special Issue
A Novel Antimicrobial Mechanism of Azalomycin F Acting on Lipoteichoic Acid Synthase and Cell Envelope
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Plants Used by Fang Populations and Phytochemical Profiling of Erismadelphus exsul

by
Morel Essono Mintsa
1,2,*,
Cédric Sima Obiang
3,
Elodie Choque
1,
Elodie Dussert
4,
Rozenn Ravallec
4,
Joseph-Privat Ondo
3,
Christophe Belloncle
2,
Brice Serge Kumulungui
5 and
François Mesnard
1,*
1
UMRt BioEcoAgro 1158-INRAE, BIOPI, Université de Picardie Jules Verne, 1 Rue des Louvels, 80000 Amiens, France
2
Laboratoire Innovation Matériau Bois Habitat (LIMBHA), Ecole Supérieure du Bois, 7 Rue Christian Pauc, 44306 Nantes, France
3
Laboratoire de Recherches en Biochimie, Université des Sciences et Techniques de Masuku, Franceville BP 943, Gabon
4
UMRt BioEcoAgro 1158-INRAE, Institut Charles Violette, Université de Lille, 59655 Lille, France
5
Centre Interdisciplinaire de Recherches Médicales de Franceville, Franceville BP 769, Gabon
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(15), 3503; https://doi.org/10.3390/molecules29153503
Submission received: 25 June 2024 / Revised: 23 July 2024 / Accepted: 24 July 2024 / Published: 26 July 2024

Abstract

:
Gabon has a rich flora, many species of which are used in traditional medicine. However, little research has been carried out on this wealth. An ethnopharmacological survey in the Fang language was carried out among traditional practitioners to collect antimicrobial medicinal plants. Phytochemical profiling of ethanolic and methanolic extracts from Erismadelphus exsul Mildbr leaves was carried out using HPLC-ESI-Q/TOF and a molecular network approach. Antibacterial activity was assessed with disk diffusion and microdilution methods, antioxidant activity via DPPH and FRAP methods, and in vitro cell viability via Cell Counting Kit-8. A total of 21 medicinal plants were collected, grouped into 10 families, of which the Fabaceae is the most represented. Erismadelphus exsul was chosen for chemical and biological studies due to its citation frequency (RCF = 0.59) and the absence of previous phytochemical studies. These studies revealed 4 major families of natural compounds and annotated 19 compounds for the first time. The crude leaf extract showed significant antioxidant and antibacterial activity. Cytotoxicity studies showed that the leaves were not cytotoxic, unlike the bark. This study underlines the importance of preserving the ancestral knowledge of the Fang populations, while showing promising results for Erismadelphus exsul.

1. Introduction

Traditional medicine makes a significant contribution to the global healthcare system, providing accessible and often culturally appropriate care to many populations. Its proper recognition is a key element of global health policy, as it enables the integration of proven practices and the valorization of ancestral knowledge, thus contributing to a more inclusive and holistic approach to healthcare [1]. Over the past decade, the use of traditional medicine has received renewed attention worldwide. For example, it accounts for a significant proportion of healthcare in China, Chile, Colombia, and India [2,3]. According to the World Health Organization (WHO), 80% of the world’s population treat their health problems with traditional remedies, due to the difficulties of access to modern medicine and the efficacy and lower toxicity of herbal treatments [4,5]. Recently, the WHO has called for the integration of traditional medicine into global healthcare systems [6]. A major challenge remains regarding the implementation of national healthcare systems that adequately develop traditional medicine policies and programs.
In Africa, and particularly in Gabon, medicinal plants play a crucial role in the treatment of various diseases, including those of microbial origin [7,8]. Gabon’s pharmacopoeia has significant potential, with a large proportion of the population using traditional medicine for primary health care [9]. Gabon is covered by primary tropical forests, offering exceptional plant potential that has yet to be fully explored [10]. The valorization of medicinal species is mainly based on ethnopharmacological surveys and phytochemical studies, through the analysis and identification of bioactive constituents. Recent advances in chemometrics, based on the processing and analysis of mass spectrometry data, have considerably improved the chemistry of living organisms [11]. In this context, liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) and the molecular network (MN) approach were used in this study to rapidly identify and target chemical components present in the leaves of Erismadelphus exsul Mildbr, a Vochysiaceae used in traditional Gabonese medicine to treat microbial diseases.
There is great interest in the search for new antimicrobial agents due to the resurgence of antibiotic-resistant infections. Essential oils and plant extracts have formed the basis of many pharmaceutical, medical, and agri-food applications. A significant proportion of the medicines currently available are derived from plants [12]. In 2011, the WHO called for intensified research into new drugs in the face of the dramatic increase in antibiotic resistance, but few new molecules are being developed. Plants synthesize a number of molecules, many with antibiotic and antioxidant activity, which can serve as reliable sources of new drugs that are relatively less toxic for humans and the environment [5].
This study focused on the selection and collection of plant species of therapeutic interest in the treatment of microbial diseases among the Fang populations of northern Gabon, with the aim of carrying out chemical and biological studies on plant species that have not been studied in the field of natural substances or for which there are insufficient data in the literature. We have thus assessed the antibacterial, antioxidant, and cytotoxic properties of the bark and leaves of Erismadelphus exsul Mildbr in view of its current use in traditional Gabonese medicine. The main priority remains the transfer of this scientific information to traditional practitioners, so that ethnopharmacological work can integrate traditional medicine into the health system where it does not exist. In this way, ethnopharmacology contributes to the advent of sustainable alternative solutions to the health problems of populations in emerging countries.

2. Results

One of the main aims of this study was to determine the ingredients used in the preparation of the remedies, to understand the methods of preparation, and to scientifically evaluate the use of these plants by the Fang populations of northern Gabon. A total of 20 traditional practitioners took part in the survey. All had already treated at least one and up to 40 patients suffering from diseases of microbial origin. The survey showed that men outnumbered women (60% versus 40%). The age range most represented among these traditional practitioners is between 40 and 50 (Table 1). In terms of education, more than half the healers have completed elementary school. According to their experience, healers were classified into three categories: those with more than 20 years’ experience (25%), those with less than 10 years’ experience (70%), and those with more than 30 years’ experience (5%) (Table 1).
In order to obtain a certain homogeneity of information on the use of medicinal plant species in relation to certain disease categories, we determined informant consensus factors (ICFs). ICFs are important because they measure the degree of agreement between informants on the use of certain plants for specific ailments, helping to validate the reliability of the traditional knowledge collected. Higher ICF values indicate greater consensus and potentially greater reliability and importance of the medicinal uses of these plants. Diseases were classified into five main groups: infection-related diseases, skin-related diseases, digestive system-related diseases, fever- and cough-related diseases, and sterility-related diseases (Table 2). The results show that the ICFs range from 0.16 to 0.83. Indeed, diseases related to digestive problems have the lowest ICF (0.16), while diseases associated with skin problems have the highest (0.83).
I.
Diseases associated with infections: urinary tract infections, pneumoniae, gastrointestinal disorder, diarrhea, chronic diarrhea, malaria, pulmonary infection, anti-poison, dysentery, mycosis, ringworms, gonorrhea, body and mouth odor, sexual weaknesses, and sexual infections;
II.
Diseases associated with skin: eczema, wounds, and burns;
III.
Diseases related to digestive problems: hemorrhoids, abdominal pain, constipation, ulcers, and stomach pain;
IV.
Diseases associated with infertility: male infertility, female infertility, fallopian tube obstruction in women, and clogged trumpets;
V.
Diseases associated with fever and coughs: bronchitis, cough, chronic cough, rheumatism, and fever.

2.1. Identified Plants: Parts Used and Method of Preparation of Recipes

The exploitation of the survey data allowed for the identification of 18 species used in traditional medicine by the Fang populations (northern ethnic group of Gabon) in the treatment of microbial diseases. A total of 21 plants were collected (Table 3), including 4 unidentified and 17 identified plants. These plant species were grouped into 10 families, of which the most representative families are, successively, the following: Fabaceae, Mimosaceae, and Sapotaceae (Figure 1). In general, bark represents the most used plant organ (59.10%), due to its ease of collection by village populations. Our results are in agreement with the work of Ngoua Meye et al. (2019), who showed in their ethnopharmacological study conducted in Northern Gabon that bark is the most used plant organ in traditional recipes [8]. Scientifically, the bark, fruits, and leaves are the best seat of the metabolites responsible for the curative properties of plants [13]. Decoction is the most widely used preparation method and remains the quickest way to extract the active ingredients [14,15]. In this study, decoction was used in 54.56% of cases versus 22.71% for maceration, with other preparation methods accounting for 22.73%. These results are in agreement with those obtained by Sima Obiang et al. (2023), on studies of aromatic medicinal plants used in northern Gabon in the locality of Oyem [16]. Water was used as an extraction solvent to prepare the recipes against microbial diseases. The oral route was the main method of administering the recipes, followed by sitz baths, with other routes being in the minority. The results obtained during the surveys enabled us to determine the main uses of the organs of several medicinal plants on the outskirts of the towns of Oyem and Bitam. Among the 21 plants collected, Erismadelphus exsul Mildbr was selected for phytochemical studies. In fact, the choice of this plant was inspired not only by information from the field but also because of the plant’s citation frequency (RCF = 0.59), far higher than that of the other plants in this study (Table 3).
Indeed, RCF (citation frequency) plays a key role in identifying the medicinal plants most commonly cited and used by traditional practitioners. Quantifying RCF enables these plants to be prioritized for more detailed phytochemical studies, as high citation frequency suggests greater recognition and perceived efficacy. Thus, plants with a high RCF can be considered promising candidates for phytochemical studies. On the other hand, plants with low RCF may require further ethnobotanical exploration to understand the reasons for their limited use. In addition to the importance of RCF, the absence of pre-existing studies on Erismadelphus exsul reinforces the value of original research. To date, very little work has been done on this plant, with the notable exception of Essono Mintsa et al. (2022) [17], who, for the first time, carried out chemical and biological studies on Erismadelphus exsul. The combination of a high RCF and the absence of studies justifies the choice of this plant.

2.2. Molecular Networks of Erismadelphus exsul Leaf Extracts

The molecular network obtained from HPLC-MS2 data in positive ionization mode of methanolic and ethanolic extracts of Erismadelphus exsul Mildbr leaves was generated from 1770 individual MS2 spectra, organized into 1356 nodes, forming five clusters (zone of connected nodes) and several selfloops (zone of unlinked nodes). Among the five clusters, four clusters (B, C, D, and E) were of particular interest to us as they grouped related nodes facilitating not only the putative identification of several compounds but also the different families of compounds. The red nodes correspond to the MS2 spectra of the compounds present in the methanolic crude extract, and the blue nodes correspond to the MS2 spectra of the ethanolic crude extract (Figure 2). A total of 19 compounds were annotated in the leaf extracts of the plant Erismadelphus exsul Mildbr (Figure 2 and Table 4). Among the compounds identified, 12 appear in unlinked nodes called selfloops (Figure 2), and the remaining 7 appear in linked-node zones (clusters B, C, D, and E). Observation of clusters A and C showed that the nodes of cluster C correspond to compounds originating exclusively from the methanolic crude extract, while those of cluster A originate predominantly from the ethanolic crude extract. Comparison of the crude formulas of cluster C with databases such as DNP (Dictionary of Natural Products) and PubChem yielded no results except for the m/z 359.228 [C21H18N4O2 + H]+ node which corresponds to Fumiquinazoline F, an antitumor compound naturally produced by Aspergillus fumigatus [18] (Table 4). The lack of correspondence of these nodes in different databases suggests that they are potentially new compounds and good candidates for isolation. Cluster E analysis shows a single matching node m/z 663.64 [C34H48O13 + H]+, mainly from the ethanolic crude extract. This fragment corresponds to the MS2 spectrum of sarmentoside B, a steroid glycoside isolated from the plant Strophanthus sarmentosus [19,20]. However, further purification and identification of the compound is required to confirm its identity. Analysis of cluster B showed a node at m/z 445.212 [C27H28N2O4 + H]+, corresponding to the MS2 spectrum of asperglaucide. This compound matched in both types of extract (Figure 2). In this cluster, we also listed two other nodes corresponding to the MS2 spectrum of asperphenamate at m/z 507.232 [C32H30N2O4 + H]+ and aurantiamide m/z 403.207 [C25H26N2O3 + H]+. The same cluster has already been described in the bark, confirming the presence of these compounds in the plant [17]. Two further nodes linked to this compound (asperphenamate) were detected with m/z 529.208 [C32H30N2O4 + Na]+ in the ethanolic extract and m/z 529.21 [C32H30N2O4 + Na]+ in the methanolic extract. An unpaired m/z 467.204 node is also observed, exclusively present in the methanolic crude extract. Cluster D analysis showed that two ion pairs (nodes) matched the GNPS (The Global Natural Product Social Molecular Networking) databases. These two MS2 spectra have never been described in the genus Erismadelphus. The fact that these compounds are present in both types of extractions somehow indicates an almost certain identification of the fragments m/z 336.222 [C17H14O6 + Na]+ and m/z 334.202 [C14H14Cl2O5 + H]+, annotated as salvianolic acid F and 3-(3,3-dichloro-2-hydroxypropyl)-6,8-dimethoxyisochromen-1-one, respectively (Figure 2). Salvianolic acids are known not only for their antioxidant activities but also for their efficacy against fibrosis, cancers, and cardiovascular diseases [21,22]. Cluster D also reveals other fragments, notably m/z 352.217 [C16H31O8 + H]+ and m/z 350.199 [C16H29O8 + H]+, corresponding, respectively, to peaks observed at retention times RT = 3.37 min and RT = 3.54 min, predominantly present in the crude ethanolic extract. It is important to underline that several compounds annotated at the level of the leaves are from fungi. In fact, chemical studies made on the bark had already shown the presence of several compounds of fungal origin which makes the studies on this plant quite interesting [17].

2.3. Antioxidant Activity

The antioxidant activity of the extracts expressed as TE/g DW (Trolox equivalent per gram dry weight) of the extracts were obtained from the Trolox calibration curve. As previously described in the bark section [17], the antioxidant activity of ethanolic extract of Erismadelphus exsul leaves was evaluated with DPPH and FRAP methods using Trolox as the standard and ascorbic acid for comparison. The results in Table 5 show that the crude extract has good iron reduction capacity; its antioxidant activity is better than ascorbic acid for the FRAP test. This high antioxidant activity of the crude extract may be due to the presence of several antioxidant compounds that act synergistically to enhance overall antioxidant activity. This synergy may enhance the reducing effect on ferric ions, making the extract more effective than ascorbic acid, which is an individual antioxidant. On the other hand, its free radical scavenging capacity is low (DPPH test). This means that the compounds present in the extract form a metal complex quite easily, one of the reasons could be the presence of specific structures such as those of flavonoids, known as antioxidants, that favor electron transfer (FRAP test) rather than hydrogen transfer (DPPH test) [23]. These results reinforce those obtained in the bark [17]. Indeed, it was shown in the bark that the plant reacted better to the FRAP test than to the DPPH test, which is in agreement with its use in traditional medicine. Indeed, like the bark, the leaves of Erismadelphus exsul are used in the form of a tea, thus facilitating the assimilation of the metabolites in the bloodstream where the iron is found. Compared to the bark, the leaves clearly exhibit less antioxidant activity (2-to-4-times less antioxidant activity). This difference in activity is partly explained by the probable interference of alkaloids present in the bark [17].

2.4. Identification of Antioxidant Molecules in Ethanolic Crude Extract

The chromatogram obtained from the ethanolic crude extract shows two major peaks, among which are an unknown compound (B) and vitexin (A) (Figure 3); the latter is known for its strong antioxidant activities and better reactivity to the FRAP assay compared to the DPPH assay [24]. In order to link the antioxidant activity of the crude extract to the compounds detected via the molecular network, we examined all the compounds of the flavonoid and isoflavonoids class supposed to be responsible for the antioxidant activity of the ethanolic leaf extract of Erismadelphus exsul. In total, six compounds were of particular interest to us among which were the following: (i) m/z 449.106 (C21H20O11+, isoorientin); (ii) m/z 433.113 (C21H20O10+, vitexin); (iii) m/z 593.1861 (C28H32O14+, fortunellin); (iv) m/z 269.637 (C16H12O4+, formononetin); (v) m/z 255.071 (C15H10O4+, 5,3′-dihydroxyflavone); and (vi) m/z 283.102 (C17H14O4+, 7-methoxy-3-(4-methoxyphenyl-4H-chromen-4-one). Among these compounds, we can notice that only vitexin has been identified with its mass spectrum in the ethanolic extract. We can therefore hypothesize that vitexin is partly responsible for the antioxidant activity of the crude ethanolic leaf extract of the plant Erismadelphus exsul.

2.5. Antimicrobial Activity

An evaluation of the antibacterial activity of the crude extracts and fractions of Erismadelphus exsul bark and leaves was performed. For this purpose, disk diffusion (determination of inhibition zone diameters IZD) and microdilution (determination of minimum inhibitory concentration MIC and bactericidal concentration MBC) methods were used. Standard antibiotics such as ticarcillin, gentamycin, and tetracycline were used as controls with inhibition diameters ranging from 10 ± 0.00 to 30 ± 0.00 mm. The antimicrobial activity of all fractions was compared to controls and crude extract with the objective of targeting the active fractions. At a concentration of 50 mg/mL, Table 6 shows the different diameters of inhibition obtained; the very first interpretation to be made is that the crude extract and fraction 5 of the leaves gave the best results with relatively higher antimicrobial activity. A similar result can be observed in the bark with the crude extract and fraction 4. The F1 bark fraction was active only on the Salmonella enterica strain (IZD 24.67 ± 0.47) and F1 leaf on almost all strains except E. coli ATCC 25922. This selective activity of the F1 fractions (leaves and bark) suggests that these fractions contain specific molecules to which these strains are sensitive or insensitive. The F4 bark fraction showed the highest inhibition diameters on Klebsiella pneumoniae MDR (IZD 22.67 ± 0.47), E. coli ATCC 25922 (IZD 20 ± 1.41), and E. coli ATCC 8739 (IZD 18 ± 0.94). Among the leaf fractions, F5 and F1 recorded higher IZD on ESBL E. coli (27.67 ± 0.47) and MDR Klebsiella pneumoniae strains (22.33 ± 0.47), respectively. Compared with the results obtained with the leaves, the bark was slightly more active on most bacterial strains. This may be explained in part by the fact that the antibacterial compounds in Erismadelphus exsul are more concentrated in the bark. In order to further our analysis and to determine the mode of action (bactericidal or bacteriostatic) of the tested samples, the MBC/MIC ratios were calculated and the results obtained were interpreted as follows: when the MBC/MIC ratio is between 1 and 2, the crude extract or fraction is bactericidal, and when this ratio is between 4 and 16, the extract is considered as being bacteriostatic [25]. Based on this principle, the results in Table 7 show that the F4 bark and F5 leaf fractions were more active on most strains, with MBC/MIC ratios ranging from 0.62 to 2.5. In fact, the F5 leaf fraction was bactericidal on all strains, and the F4 fraction was bactericidal on most strains, with the exception of E. coli ESBL, where it was bacteriostatic. Thus, analysis and interpretation of these results indicate that most antibacterial compounds in Erismadelphus exsul (leaves and bark) are mainly eluted in the F4 and F5 fractions.

2.6. Cytotoxicity of Crude Leaf and Bark Extracts of Erismadelphus exsul

Cytotoxicity tests allow for the determination of whether the tested sample inhibits the overall growth of cancer cells and healthy cells. For this purpose, depending on the traditional use of each plant organ (leaves and bark), two cell lines were selected. In the context of using the leaves as an ointment for microbial skin diseases, it was imperative to test its activity on healthy human keratinocyte cells (HaCaT, epidermal cells). We also chose human colon cancer epithelial cells (Caco-2) to test the antiproliferative activity of the bark given its use as a tea. Cytotoxic activity analysis was performed at different extract concentrations ranging from 10 to 500 µg/mL. The IC50 value is determined from the percentage of cell viability compared to the control. The results show that the leaf extract has no cytotoxic activity on healthy HaCaT cells after 24 h of exposure (IC50 184.01 ± 24.64 µg/mL) (Figure 4B). However, bark showed moderate cytotoxic activity on colon cancer cells with an IC50 of 76.35 ± 6.28 µg/mL (Figure 4C). The results obtained in the cytotoxicity study are in line with the plant’s traditional use. Indeed, the leaves of this plant are traditionally applied directly to the skin in the form of an ointment. The absence of cytotoxicity observed on healthy skin cells reinforces the reliability of this traditional use, confirming that topical application of the plant is safe for the skin. In view of these rather interesting results, it was necessary to understand the behavior of each part of the plant on the two cell lines. Thus, we evaluated the cytotoxic activity of the bark on healthy HaCaT cells and that of leaves on Caco-2 colon cancer cells. The results obtained show that leaves have no cytotoxic activity on colon cancer cells (IC50 221.73 ± 40.34 µg/mL) (Figure 4A) while the bark significantly inhibits the proliferation of epidermal cells with an IC50 35.51 ± 3.63 µg/mL (Figure 4D). These results suggest that some compounds present in the bark exert cytotoxic activity against epidermal cells [17]. By making a comparative study of the main families of molecules present in the two parts of the plant, only the cyclopeptide alkaloids and quinolines are absent in the leaves [17]. From this observation, we can easily understand that the moderate antiproliferative activity of the plant is due to the presence of these alkaloids in the bark [17]. The results obtained in the cytotoxicity study are in accordance with the traditional use of the plant. However, as this study was carried out on two cell lines, we cannot conclude that it has cytotoxic activity, as the NCI (National Institute of Cancer) in the United States recommends that cytotoxicity tests be carried out on about sixty cell lines before declaring an extract or the tested compounds to be active [26].

3. Discussion

Plants produce secondary metabolites that have specific functions such as protection of the plant against pathogens, allelopathy, and plant–microbe symbiosis at the root level and can also serve as an attractant for pollinators. However, these compounds have several biological properties that are of interest to researchers, especially in the discovery of new molecules that are active against several pathologies in human, animal, and plant health. The primary objective of this work was to identify the plants used by the Fang populations in northern Gabon for the treatment of microbial diseases, with the aim of developing and scientifically validating the use of these plants by the local populations. Therefore, an ethnopharmacological survey was undertaken with about twenty traditional practitioners. Indeed, the selection of plants on the basis of ethnopharmacological data increases the percentage of resulting in a much more active extract. Our field study resulted in the collection of 21 plants, of which 17 were identified. Among the identified plants, Erismadelphus exsul Mildbr was selected for phytochemical studies. The choice of this plant was based not only on the limited number of studies but also on the frequency of citation of the plant during the surveys. The second objective was to characterize in a more targeted way the compounds present in the leaf part of the plant. To achieve this, a combined approach of LC-MS/MS mass spectrometry and molecular networks was used. The first step was the extraction of the bioactive compounds from the leaves. For this crucial extraction step, the ideal was to directly recover the traditional extract or to work under the same conditions as the traditional practitioners in order to have approximately comparable results in terms of biological activities. Given the absence of solvents commonly used in the preparation of traditional recipes (palm wine, sugarcane wine, palm oil, and whisky), we opted for an alcoholic extraction based on ethanol and methanol, due to their recognized effectiveness in extracting a wide range of bioactive compounds. Once the choice of solvent had been made, maceration (cold extraction) was chosen as the extraction method. The advantage of this method is that it limits the loss or alteration of fragile organic chemical species, which can degrade at high temperatures. Indeed, depending on the type of extraction and the polarity of the solvent, the variability of the active ingredients can be modified, as can their pharmacological activity. From the leaves of Erismadelphus exsul, about twenty compounds were obtained, thus completing the work of Essono Mintsa et al. (2022), who previously identified 18 compounds in the bark, generally belonging to families of molecules such as cyclopeptide alkaloids and quinolines, polyphenols such as flavonoids, and isoflavoinoids, glycerophospholipids, and steroids [17]. Molecular networks designed on the basis of MS/MS spectra not only enabled putative identification but also provided visibility on the main molecular families present in the leaf part, namely (i) flavonoids, (ii) isoflavoinoids, (iii) lignans, (iv) steroids, (v) oligopeptides, (vi) coumarins, and vii) tryptophan alkaloids. Taking into account the results obtained by Essono Mintsa et al. (2022) on the chemical part of the barks, a certain homogeneity was observed in the two types of organs. The main difference in terms of families of molecules between the two types of organs (bark and leaves) is the absence of cyclopeptide alkaloids and quinolines in the leaf part [17]. In fact, only these two families of molecules were not found in the leaves. No concrete explanation has been found for this major difference between the two organs. Nevertheless, some studies have shown that alkaloids are produced as secondary metabolites in response to environmental stress or to provide a defense mechanism against disease-causing aggressions in plants. The third objective of this work was to test the antibacterial and antioxidant activities and to evaluate the cytotoxicity of the leaves and bark of Erismadelphus exsul in view of its traditional uses. The results of the antibacterial activities show a high activity of the ethanolic fractions F5 (leaf) and F4 (bark). Based on previous works, it was already demonstrated that the bark of Erismadelphus exsul possesses high antimicrobial activity and that compounds such as Mauritine A, Mauritine F, Mauritine A N-Oxide, 8-Deoxoantidesmone, 8-Dihydroantidesmone, and Antidesmone are partly responsible for the antimicrobial activity of the bark of Erismadelphus exsul [17]. By analogy, we can say that the antibacterial activity observed for the F4 bark fraction is partly due to the presence of these compounds. However, a more targeted mass spectrometry analysis would be important to confirm this hypothesis. In addition, the crude extract and the F5 leaf fraction were bactericidal on the majority of the strains; in view of the chemical groups present in the leaf part, we can assume that the presence of families of molecules such as polyphenols and alkaloids may be responsible for this activity. The evaluation of the antioxidant activity of the leaves shows that the plant reacts better to the FRAP test than to the DPPH test. This means that the compounds present in the extracts and fractions of Erismadelphus exsul quite easily form a metal complex. Indeed, the presence of specific structures such as those of flavonoids favor electron transfer (FRAP test) rather than hydrogen transfer (DPPH test). Numerous studies in the literature show that phenolic compounds such as flavones, flavonoids, and isoflavonoids have a great capacity to scavenge free radicals and chelate transition metals such as iron [27]. The high reactivity of Erismadelphus exsul leaves in the FRAP assay may be related to the presence of several flavonoids and isoflavonoids. Considering the antioxidant results of the bark part of Erismadelphus exsul, we can say that the bark has much more antioxidant activity than the leaf [17]. In this study, it was also a question of proving the safety of this plant. Thus, a study of cytotoxicity was conducted both in the leaf part and in the bark. The results obtained show that the leaves of Erismadelphus exsul do not present any cytotoxicity for healthy cells of the skin. These results are in agreement with the traditional use of the leaves. Indeed, the leaves of Erismadelphus exsul are used as ointment in the case of skin diseases such as mycosis. In contrast to the leaves, the bark inhibits not only the proliferation of colon cancer cells but also human keratinocyte cells.

4. Materials and Methods

4.1. Study Area

Gabon is a small Central African country marked by a forest that covers 85% (nearly 230,000 km2) of its national territory [28]. It is bordered to the northeast by Cameroon, to the northwest by Equatorial Guinea, and to the east by Congo-Brazzaville. Gabon is part of the Congo Basin, the second largest forest in the world after the Amazon. At present, the Gabonese forest is probably the richest in plant species with nearly 20% of the endemic species [29]. Gabon has 13 national parks and 9 provinces covering an area of 267,667 km2. This study took place in the province of Woleu-Ntem (northern Gabon) precisely in the cities of Oyem, the provincial capital, and Bitam (Figure 5).

4.2. Ethnopharmacological Survey

Ethnopharmacological surveys were conducted between August 2018 and January 2019 in villages located 32 Km from Bitam (Nkoum adzap, Mvane essabeigne, Kone-essong, Nkine, Abem, and Bilé’e-bidoua) and between 15 and 30 km from Oyem (Akam essatouk, Oveng, Adzap be endeng nkodjè, and Akok be essono-obono nkodjè). Information was collected from about 20 traditional practitioners who agreed to share their knowledge of antimicrobial plants and related diseases. The interviewees were identified through the local leaders of the traditional healers committee in said province. The interviewers completed a pre-designed questionnaire. Our interview guide included questions about the local name of the plant, the organ used, the method of preparation, the disease treated, and the age and education level of the informant. It is important to emphasize the fact that healers focus much more on the symptoms, such as fever, cough, and diarrhea, which are a sometimes-direct result of the disease, and not the biological etiology such as the infectious agent responsible for the disease. The survey was conducted in the vernacular Fang language, respecting the traditions and customs of local populations and traditional practitioners.

4.3. Collection and Species Identification

Fresh plant samples were collected with secateurs and were labeled and transported in a UV-resistant plastic bag. An herbarium sheet was made where the plants were collected, and plant identification was carried out at Gabon’s national herbarium IPHAMETRA (Institut de Pharmacopée et de Médecine Traditionnelle). An agreement with the focal point of the convention on biological diversity was signed before the work began.

4.4. Quantitative Analysis of Ethnopharmacological Data

Descriptive statistical methods were used to analyze ethnopharmacological survey data and quantitative indices, including the informant consensus factor (ICF) and relative citation frequency (RCF). Data were presented as proportions and percentages. ICF and RFC values were calculated using the following formulas: ICF = [ N u r N t ] / [ N u r 1 ] .
Where “Nur” is the number of use reports for a particular disease category and “Nt” indicates the number of taxa used for a particular disease category [30,31]. The range of ICF values is between 0 and 1 (0 < ICF < 1) [32].
RCF = C F N   Or   Citation   Frequency   ( CF ) = N u m b e r   o f   c i t a t i o n s   o f   a   p a r t i c u l a r   s p e c i e s T o t a l   n u m b e r   o f   c i t a t i o n s   o f   a l l   s p e c i e s × 100
“N” is the total number of informants contributing to the survey [33]. The range of RCF values is between 0 and 1 (0 < RCF < 1).

4.5. Extraction and Fractionation

The extraction protocol for Erismadelphus exsul bark and leaves was performed according to the method used by Essono Mintsa et al., 2023 [25]. After drying and grinding, 400 g of powder were subjected to stirred maceration with 1500 mL of 70% ethanol for 24 h. The extract obtained was filtered under vacuum and concentrated using a rotary evaporator to produce crude extracts. These extracts were then fractionated via flash chromatography on an 80 g Reveleris® Grace Silica PF-50SIHC-F0080 cartridge (Thermo Fisher Scientific, Rheinland-Pfalz, Germany) using a CH2Cl2 gradient with increasing proportions of MeOH (100:0 to 0:100) at a fixed flow rate of 60 mL/min. The fractions obtained were pooled via thin-layer chromatography (TLC) and analyzed via HPLC-QTOF-HRES to identify potential new compounds.

4.6. Data-Dependent LC-HR-ESI-MS2 Analysis

LC-HR-ESI-MS2 analyses and molecular networking were carried out in accordance with methods described previously by Essono Mintsa et al., 2022 [17]. Samples were analyzed on an Agilent 6530 mass spectrometer (Agilent, Santa Clara, CA, USA) with an ESI source in positive ion mode, coupled to high-performance liquid chromatography on a Sunfire® C18 column (Waters Corp, Milford, MA, USA) (150 × 2.1 mm, 3.5 µm). A standard elution gradient with H2O and MeOH mobile phases, containing 0.1% formic acid, was applied at a flow rate of 0.25 mL/min, ranging from 5:95 to 100:0 (MeOH + 0.1% HCOOH) over 40 min. LC-UV and MS data were processed with MassHunter Workstation software 11.0, enabling rapid identification of the chemical components present in the samples and contributing to understanding the therapeutic properties of the extracts studied.

4.7. Molecular Networking Parameters

Molecular networking was performed according to a protocol already described by Essono Mintsa et al. (2022) [17]. Conversion of MS2 data from .d format (Agilent Technologies, Massy, France) to .mzXML format with MSConvert is the first step in molecular networking. Next, the .mzXML files are processed with MZmine 2 v32 for mass detection, using a noise level of 3.0 E3 and specific parameters for the ADAP chromatogram builder and ADAP wavelet deconvolution algorithm. MS2 scans are matched to strict m/z and RT tolerances, and isotopes are grouped to defined tolerances. The join alignment module aligns peaks to m/z and RT tolerances. The .mgf spectral data files and .csv metadata are exported to GNPS-FBMN to generate the molecular network, with MS/MS mass and fragment ion tolerances of 0.02 Da. Molecular array data are then analyzed and visualized using Cytoscape software (version 3.9.0).

4.8. Antioxidant Activity: FRAP and DPPH Assays

The Ferric Reducing Power (FRAP) and DPPH assays were carried out in accordance with methods described previously by Essono Mintsa et al., 2022 [17]. The FRAP reagent was prepared by mixing 300 mM acetate buffer pH 3.6, 10 mM TPTZ solution, and 20 mM FeCl3 in a 10:1:1 ratio just prior to use [17]. Trolox (Sigma-Aldrich, St. Louis, MI, USA) was used as a standard. From a 750 µM stock solution of Trolox prepared in ethanol, serial dilutions were made to obtain a concentration ranging from 50 µM to 375 µM. Each standard or sample dilution (50 µL) was combined with 950 µL of FRAP solution. Each analysis was performed in triplicate, then incubated at 37 °C for 30 min. Absorbances were read at 593 nm using a UV spectrophotometer (Anthelie Advanced, Seconam, Shimadzu, France).

4.9. Bacterial Germs Tested

The bacteria used (Escherichia coli ATCC 25922, Escherichia coli ATCC 8739, Klebsiella pneumoniae MDR, Escherichia coli ESBL, and Salmonella enterica) in this study were obtained at the Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF) in Gabon.

4.10. Antibacterial Test

The sensitivity of microorganisms to plant extracts was studied using the diffusion method [25]. From the bacterial colonies, an inoculum was prepared at a density equivalent to 0.5 McFarland on Muller-Hinton Agar medium (Liofilchem, Roseto, Italy). After inoculation of the bacterial suspension, the agar was dried for 10 min. Then, sterile Wattman paper discs impregnated with 20 µL of extract prepared at a concentration of 100 µg/mL (diluted with 1% DMSO) were placed in the Petri dishes and incubated for 18–24 h at 36 °C. Reference antibiotics such as ticarcillin, tetracycline, and gentamicin were used as positive controls, and each test was performed in triplicate. Minimum inhibitory concentration (MICs) and bactericidal concentration (MBCs) were determined using the microdilution method on sterile 96-well microplates [34]. Series of seven dilutions of each extract (twofold dilution ranging from 0.0049 to 5 mg/mL) were performed in Muller–Hinton nutrient broth (Liofilchem, Roseto, Italy). In order to determine the MBC, the nutrient agar was inoculated with 100 µL of the well contents. After 24 h of incubation at 37 °C, the MBC was determined.

4.11. Cell Culture

The cell lines used in this study were selected based on the traditional uses of the two plant organs (leaves and bark); they are human colon epithelial cells, Caco-2 (accession number 86010202, European collection of authenticated cell cultures (ECACC), Salisbury, UK), and immortalized human keratinocyte cells, HaCaT (accession number 300493, Cell Lines Service GmbH, Eppelheim, Germany) [25].

4.12. CCK-8 Cell Viability Assays

The Cell Counting Kit-8 (CCK-8) assay (Dojindo Laboratories, Kumamoto, Japan) was used to determine cell viability according to the previously described protocol by Essono Mintsa et al. (2023) [25]. The percentage of live cells in DMSO was used to calculate cell viability, using GraphPad Prism 9.3.0 software by applying the following formula:
( % )   Cell   viability = M e a n   O D   o f   t r e a t e d   c e l l s M e a n   O D   o f   D M S O   c o n t r o l   c e l l s × 100  
Data were expressed as mean ± standard deviation (SD) of independent triplicate experiments (N = 3), and results were analyzed using a one-way analysis of variance (ANOVA), the Kruskal–Wallis test, and Dunn’s post hoc test.

5. Conclusions

The ethnopharmacological survey carried out among traditional practitioners made it possible to collect 21 medicinal plants used by the Fang populations of northern Gabon in the treatment of microbial diseases. This survey revealed the different parts of the plants used in the preparation of medicinal recipes for microbial control. Thus, through a combined approach of mass spectrometry and molecular networks, 19 compounds were identified. The results of the antibacterial activity analyses for the plant show that, apart from the crude extracts, the fractions F4 (bark) and F5 (leaf) have the best antimicrobial activity. This study also shows that the presence of families of molecules such as polyphenols of flavonoids and isoflavonoids provide the plant with good antioxidant activity. Cytotoxicity studies of Erismadelphus exsul bark and leaves show that the leaf does not show any cytotoxicity towards the two cell lines (Caco-2 and HaCaT), and that the bark shows a moderate cytotoxicity on both cell types. The results obtained in this study are rather encouraging, considering the traditional use of the plant. These results provide preliminary indications of the plant’s therapeutic potential. However, to gain a full understanding, further research is required. In particular, more advanced studies, including in vivo tests that take into account compound bioavailability and metabolism, are essential. In addition, it would be useful to examine in detail the phytochemical composition of each plant collected in this survey to gain greater insight into their therapeutic efficacy.

Author Contributions

Conceptualization, F.M. and B.S.K.; Methodology, M.E.M., C.S.O., E.C. and E.D.; Investigation, M.E.M., C.S.O. and J.-P.O.; Writing of draft, M.E.M.; Data analysis, M.E.M., E.C. and E.D.; Resources, R.R., C.B. and J.-P.O.; Supervision, F.M. and B.S.K.; Revision and approval of final version, F.M., B.S.K., C.B., R.R., M.E.M., C.S.O., J.-P.O., E.C. and E.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not Applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, X.; Li, H.; Lucero-Prisno, D.E.; Abdullah, A.S.; Huang, J.; Laurence, C.; Liang, X.; Ma, Z.; Mao, Z.; Ren, R.; et al. What Is Global Health? Key Concepts and Clarification of Misperceptions: Report of the 2019 GHRP Editorial Meeting. Glob. Health Res. Policy 2020, 5, 14. [Google Scholar] [CrossRef] [PubMed]
  2. Byk, C. Chapitre 5. Le droit international et la reconnaissance de la médecine traditionnelle. J. Int. Bioéthique Déthique Sci. 2021, 32, 87–96. [Google Scholar] [CrossRef]
  3. Assemblée mondiale de la Santé, 56. Médecine Traditionnelle: Rapport du Secrétariat; Organisation mondiale de la Santé: Geneva, Switzerland, 2003. [Google Scholar]
  4. Novais, M.H.; Santos, I.; Mendes, S.; Gomes, C. Studies on Pharmaceutical Ethnobotany in Arrabida Natural Park (Portugal). J. Ethnopharmacol. 2004, 93, 183–195. [Google Scholar] [CrossRef]
  5. Al-Rifai, A.; Aqel, A.; Al-Warhi, T.; Wabaidur, S.M.; Al-Othman, Z.A.; Badjah-Hadj-Ahmed, A.Y. Antibacterial, Antioxidant Activity of Ethanolic Plant Extracts of Some Convolvulus Species and Their DART-ToF-MS Profiling. Evid. Based Complement. Alternat. Med. 2017, 2017, 1–9. [Google Scholar] [CrossRef] [PubMed]
  6. World Health Organization. Programme on Traditional Medicine. In General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine; World Health Organization: Geneva, Switzerland, 2000. [Google Scholar]
  7. Bading Taika, B.; Bouckandou, M.; Souza, A.; Bourobou Bourobou, H.P.; MacKenzie, L.S.; Lione, L. An Overview of Anti-Diabetic Plants Used in Gabon: Pharmacology and Toxicology. J. Ethnopharmacol. 2018, 216, 203–228. [Google Scholar] [CrossRef] [PubMed]
  8. Ngoua-Meye-Misso, R.-L.; Sima-Obiang, C.; Ndong, J.D.L.C.; Ndong-Atome, G.-R.; Ondo, J.P.; Ovono Abessolo, F.; Obame-Engonga, L.-C. Medicinal Plants Used in Management of Cancer and Other Related Diseases in Woleu-Ntem Province, Gabon. Eur. J. Integr. Med. 2019, 29, 100924. [Google Scholar] [CrossRef]
  9. Towns, A.M.; Ruysschaert, S.; van Vliet, E.; van Andel, T. Evidence in Support of the Role of Disturbance Vegetation for Women’s Health and Childcare in Western Africa. J. Ethnobiol. Ethnomed. 2014, 10, 42. [Google Scholar] [CrossRef] [PubMed]
  10. Towns, A.M.; Quiroz, D.; Guinee, L.; de Boer, H.; van Andel, T. Volume, Value and Floristic Diversity of Gabon׳s Medicinal Plant Markets. J. Ethnopharmacol. 2014, 155, 1184–1193. [Google Scholar] [CrossRef] [PubMed]
  11. Beniddir, M.A.; Kang, K.B.; Genta-Jouve, G.; Huber, F.; Rogers, S.; van der Hooft, J.J.J. Advances in Decomposing Complex Metabolite Mixtures Using Substructure- and Network-Based Computational Metabolomics Approaches. Nat. Prod. Rep. 2021, 38, 1967–1993. [Google Scholar] [CrossRef]
  12. Abedini, A.; Roumy, V.; Mahieux, S.; Biabiany, M.; Standaert-Vitse, A.; Rivière, C.; Sahpaz, S.; Bailleul, F.; Neut, C.; Hennebelle, T. Rosmarinic Acid and Its Methyl Ester as Antimicrobial Components of the Hydromethanolic Extract of Hyptis Atrorubens Poit. (Lamiaceae). Evid.-Based Complement. Altern. Med. ECAM 2013, 2013, 604536. [Google Scholar] [CrossRef]
  13. Al-Adhroey, A.H.; Al-Abhar, Y.M.; Noman, N.M.; Al-Mekhlafi, H.M. Ethnopharmacological Survey of Herbal Remedies Used for Treating Malaria in Yemen. J. Herb. Med. 2020, 21, 100332. [Google Scholar] [CrossRef]
  14. Feuya Tchouya, G.R.; Souza, A.; Tchouankeu, J.C.; Yala, J.-F.; Boukandou, M.; Foundikou, H.; Nguema Obiang, G.D.; Fekam Boyom, F.; Mabika Mabika, R.; Zeuko´o Menkem, E.; et al. Ethnopharmacological Surveys and Pharmacological Studies of Plants Used in Traditional Medicine in the Treatment of HIV/AIDS Opportunistic Diseases in Gabon. J. Ethnopharmacol. 2015, 162, 306–316. [Google Scholar] [CrossRef]
  15. Tjeck, O.P.; Souza, A.; Mickala, P.; Lepengue, A.N.; M’Batchi, B. Bio-Efficacy of Medicinal Plants Used for the Management of Diabetes Mellitus in Gabon: An Ethnopharmacological Approach. J. Intercult. Ethnopharmacol. 2017, 6, 206–217. [Google Scholar] [CrossRef] [PubMed]
  16. Obiang, C.S.; Misso, R.-L.N.M.; Mba, T.N.; Ondo, J.P.; Engonga, L.C.O.; Emvo, E.N. Ethnopharmacological Survey of Aromatic Medicinal Plants Used in the Treatment of the Most Recurrent Diseases in the Locality of Oyem, Gabon. Adv. Tradit. Med. 2023, 24, 191–210. [Google Scholar] [CrossRef]
  17. Essono Mintsa, M.; Otogo N’nang, E.; Choque, É.; Siah, A.; Jacquin, J.; Muchembled, J.; Molinié, R.; Roulard, R.; Cailleu, D.; Beniddir, M.A.; et al. Combined LC-MS/MS and Molecular Networking Approach Reveals Antioxidant and Antimicrobial Compounds from Erismadelphus Exsul Bark. Plants 2022, 11, 1505. [Google Scholar] [CrossRef] [PubMed]
  18. Ames, B.D.; Liu, X.; Walsh, C.T. Enzymatic Processing of Fumiquinazoline F: A Tandem Oxidative-Acylation Strategy for the Generation of Multicyclic Scaffolds in Fungal Indole Alkaloid Biosynthesis. Biochemistry 2010, 49, 8564–8576. [Google Scholar] [CrossRef] [PubMed]
  19. Wibowo, J.T.; Kellermann, M.Y.; Versluis, D.; Putra, M.Y.; Murniasih, T.; Mohr, K.I.; Wink, J.; Engelmann, M.; Praditya, D.F.; Steinmann, E.; et al. Biotechnological Potential of Bacteria Isolated from the Sea Cucumber Holothuria Leucospilota and Stichopus Vastus from Lampung, Indonesia. Mar. Drugs 2019, 17, 635. [Google Scholar] [CrossRef]
  20. Callow, R.K.; Taylor, D.A.H. 429. The Cardio-Active Glycosides of Strophanthus Sarmentosus P.DC. “Sarmentoside B” and Its Relation to an Original Sarmentobioside. J. Chem. Soc. Resumed 1952, 2299–2304. [Google Scholar] [CrossRef]
  21. Ma, L.; Tang, L.; Yi, Q. Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer. Front. Pharmacol. 2019, 10, 97. [Google Scholar] [CrossRef]
  22. Wang, Q.; Hu, Z.; Li, X.; Wang, A.; Wu, H.; Liu, J.; Cao, S.; Liu, Q. Salviachinensines A–F, Antiproliferative Phenolic Derivatives from the Chinese Medicinal Plant Salvia Chinensis. J. Nat. Prod. 2018, 81, 2531–2538. [Google Scholar] [CrossRef]
  23. Mira, L.; Tereza Fernandez, M.; Santos, M.; Rocha, R.; Helena Florêncio, M.; Jennings, K.R. Interactions of Flavonoids with Iron and Copper Ions: A Mechanism for Their Antioxidant Activity. Free Radic. Res. 2002, 36, 1199–1208. [Google Scholar] [CrossRef] [PubMed]
  24. Li, H.; Cao, D.; Yi, J.; Cao, J.; Jiang, W. Identification of the Flavonoids in Mungbean (Phaseolus radiatus L.) Soup and Their Antioxidant Activities. Food Chem. 2012, 135, 2942–2946. [Google Scholar] [CrossRef] [PubMed]
  25. Essono Mintsa, M.; Kumulungui, B.S.; Obiang, C.S.; Dussert, E.; Choque, E.; Herfurth, D.; Ravallec, R.; Ondo, J.-P.; Mesnard, F. Cytotoxicity and Identification of Antibacterial Compounds from Baillonella Toxisperma Bark Using a LC-MS/MS and Molecular Networking Approach. Metabolites 2023, 13, 599. [Google Scholar] [CrossRef] [PubMed]
  26. Zghaib, Z. Etude Des Effets Cytotoxique et Antitubuline Des Imidazoquinoxalines: Etude Du Mécanisme d’action Par Une Analyse Transcriptomique. Ph.D. Thesis, The University of Montpellier, Montpellier, France, 2016. [Google Scholar]
  27. Mu, H.; Bai, Y.-H.; Wang, S.-T.; Zhu, Z.-M.; Zhang, Y.-W. Research on Antioxidant Effects and Estrogenic Effect of Formononetin from Trifolium Pratense (Red Clover). Phytomedicine Int. J. Phytother. Phytopharm. 2009, 16, 314–319. [Google Scholar] [CrossRef]
  28. Djéki, J. Espace, territoire et communications au Gabon: Analyse des dysfonctionnements des voies de communication en zone équatoriale. NETCOM Réseaux Commun. Territ. Netw. Commun. Stud. 1997, 11, 300–312. [Google Scholar] [CrossRef]
  29. Wilks, C. La Conservation des Ecosystèmes Forestiers du Gabon; IUCN: Gland, Switzerland, 1990; ISBN 978-2-88032-988-4. [Google Scholar]
  30. Wilson, E.O.; Peter, F.M. Screening Plants for New Medicines. In Biodiversity; National Academies Press: Washington, DC, USA, 1988. [Google Scholar]
  31. Qureshi, R. Floristic and Ethno Botanical Study of Desert-Nara Region, Sindh; ResearchGate GmbH: Berlin, Germany, 2004. [Google Scholar]
  32. Tahira, I.; Sultana, N.; Hanif, N. Identification of Aflatoxins and Ochratoxin A in Selected Imported Pet Food. J. Bioresour. Manag. 2015, 2, 5. [Google Scholar] [CrossRef]
  33. Vitalini, S.; Iriti, M.; Puricelli, C.; Ciuchi, D.; Segale, A.; Fico, G. Traditional Knowledge on Medicinal and Food Plants Used in Val San Giacomo (Sondrio, Italy)—An Alpine Ethnobotanical Study. J. Ethnopharmacol. 2013, 145, 517–529. [Google Scholar] [CrossRef]
  34. Obiang, C.S.; Misso, R.L.N.M.; Atome, G.R.N.; Obame, R.B.M.; Ondo, J.P.; Engonga, L.C.O.; Emvo, E.N. Antimicrobial, Antioxidant, Anti-Inflammatory and Cytotoxic Study of Extracts of Guibourtia tessmanii (Harms) J. Léonard from Gabon. Clin. Phytosci. 2021, 7, 45. [Google Scholar] [CrossRef]
Figure 1. Ethnopharmacological surveys showing the frequency of botanical families studied.
Figure 1. Ethnopharmacological surveys showing the frequency of botanical families studied.
Molecules 29 03503 g001
Figure 2. Molecular network analysis of Erismadelphus exsul crude ethanolic extract and leaf fractions obtained with the GNPS platform and visualized with Cytoscape 3.9.0 software. This molecular network shows compounds annotated on each cluster (compounds 1 to 7) and compounds annotated at unlinked nodes called selfloops (compounds 8 to 19). The names of the compounds identified are as follows: (1) Asperphenamate, (2) Asperglaucide, (3) Aurantiamide, (4) Fumiquinazoline F, (5) 3-(3,3-dichloro-2-hydroxypropyl)-6,8-dimethoxyisochromen-1-one, (6) salvianolic acid F, (7) Sarmentoside B, (8) Vitexin, (9) Kaempferol 3-neohesperidoside, (10) Formononetin, (11) Grandisin, (12) Isoorientin, (13) Beauvericin, (14) Pheophorbide A, (15) 4′, 7-Dimethoxyisoflavone, (16) 5,3′-Dihydroxyflavone, (17) Drostanolone, (18) Ervatamine, and (19) (E)-3-(4-methoxyphenyl)-1-[2,4,6-trimethoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one. Nodes in red represent nodes from the crude extract and those in blue represent nodes from the fractions.
Figure 2. Molecular network analysis of Erismadelphus exsul crude ethanolic extract and leaf fractions obtained with the GNPS platform and visualized with Cytoscape 3.9.0 software. This molecular network shows compounds annotated on each cluster (compounds 1 to 7) and compounds annotated at unlinked nodes called selfloops (compounds 8 to 19). The names of the compounds identified are as follows: (1) Asperphenamate, (2) Asperglaucide, (3) Aurantiamide, (4) Fumiquinazoline F, (5) 3-(3,3-dichloro-2-hydroxypropyl)-6,8-dimethoxyisochromen-1-one, (6) salvianolic acid F, (7) Sarmentoside B, (8) Vitexin, (9) Kaempferol 3-neohesperidoside, (10) Formononetin, (11) Grandisin, (12) Isoorientin, (13) Beauvericin, (14) Pheophorbide A, (15) 4′, 7-Dimethoxyisoflavone, (16) 5,3′-Dihydroxyflavone, (17) Drostanolone, (18) Ervatamine, and (19) (E)-3-(4-methoxyphenyl)-1-[2,4,6-trimethoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one. Nodes in red represent nodes from the crude extract and those in blue represent nodes from the fractions.
Molecules 29 03503 g002aMolecules 29 03503 g002b
Figure 3. HPLC-UV-MS analyses of the ethanolic crude extract of Erismadelphus exsul leaves and the mass spectrum of vitexin.
Figure 3. HPLC-UV-MS analyses of the ethanolic crude extract of Erismadelphus exsul leaves and the mass spectrum of vitexin.
Molecules 29 03503 g003
Figure 4. The cytotoxicity of Erismadelphus exsul bark and leaves on HaCaT and Caco-2 cells. Differences were observed in comparison with the control (CTL). (A) IC50 = 221.73 ± 40.34 µg/mL; (B) IC50 = 184.01 ± 24.64 µg/mL; (C) IC50 = of 76.35 ± 6.28 µg/mL; (D) IC50 = 35.51 ± 3.63 µg/mL. * p = 0.0304, ** p = 0.0037, *** p = 0.0006, and **** p < 0.0001 were considered statistically significant and ns was considered insignificant.
Figure 4. The cytotoxicity of Erismadelphus exsul bark and leaves on HaCaT and Caco-2 cells. Differences were observed in comparison with the control (CTL). (A) IC50 = 221.73 ± 40.34 µg/mL; (B) IC50 = 184.01 ± 24.64 µg/mL; (C) IC50 = of 76.35 ± 6.28 µg/mL; (D) IC50 = 35.51 ± 3.63 µg/mL. * p = 0.0304, ** p = 0.0037, *** p = 0.0006, and **** p < 0.0001 were considered statistically significant and ns was considered insignificant.
Molecules 29 03503 g004
Figure 5. Map of Gabon showing the location of study area Woleu-Ntem. The red circle represents the cities where the surveys were carried out (Oyem, Bitam).
Figure 5. Map of Gabon showing the location of study area Woleu-Ntem. The red circle represents the cities where the surveys were carried out (Oyem, Bitam).
Molecules 29 03503 g005
Table 1. Socio-demographic data of traditional healers.
Table 1. Socio-demographic data of traditional healers.
VariableCategoriesNumber of Traditional PractitionersPercentage (%)
Level of EducationUneducated210
Primary school315
High school735
College315
Postgraduate qualification525
Age (years)<20315
(20–40)210
(40–50)1260
(60–70)315
>3015
Experience (years)>20525
<101470
GenderMale1260
Female840
Table 2. Disease categories based on the information consensus factor (ICF).
Table 2. Disease categories based on the information consensus factor (ICF).
CategoriesNurNtICF
I Diseases associated with infections18120.35
II Diseases associated with skin1330.83
III Diseases related to digestive problems760.16
IV Diseases associated with fever and coughs950.50
V Diseases associated with infertility640.40
Nur: Number of use reports for particular disease category; Nt: Number of taxa used for a particular disease category.
Table 3. Antimicrobial plants used by the Fang populations of northern Gabon.
Table 3. Antimicrobial plants used by the Fang populations of northern Gabon.
SpeciesFamilyVernacular Names aParts UsedRecipes
Preparation
Mode of AdministrationIndication of Disease TreatedRCF
Erismadelphus exsul MildbrVochysiaceaeEssang afaneBLDecoctionOral and dermal routeUrinary tract infections, pneumoniae, bronchitis, and sexually transmitted diseases0.59
Baillonella toxisperma PierreSapotaceaeAdzapBLDecoctionOral routeFever, gastrointestinal pain, and urinary diseases, rheumatic pains, mycosis, ringworms, wounds, and malaria0.39
Morinda lucida
Benth
RubiaceaeAkengBLDecoctionOral routeInternal hemorrhoids and pulmonary infections0.25
Petersianthus macrocarpus
P. Beauv
LecythidaceaeAbingBLDecoctionOral routeCough, fever, and sexually transmitted diseases0.15
Entandrophragma cylindricum
(Sprague) Sprague
MeliaceaeAssiéeBLDecoctionOral routeStomach pain and abdominal pain0.05
Ongokea gore
(Hua) Pierre
OlacaceaeAngeukkBDecoctionOral routeConstipation0.25
Trichoscypha acuminate
Engl.
AnacardiaceaeAmvoutBLDecoctionOral and rectal routeMale infertility and dysentery0.25
Pentaclethra macrophylla
Benth.
MimosaceaeEbeigneBDecoctionOral routeDiarrhea0.10
UnidentifiedUnidentifiedMebamane
Elé’e
BDecoctionOral routeAnti-poison and fever0.40
Omphalocarpum elatum
Miers
SapotaceaeMebeignemegôneBMacerationOral routeMale infertility and chronic diarrhea0.40
Pycnanthus angolesis
(Welw.) Warb.
MyristicaceaeEtengBInfusionOral routePowerful antibiotic against sexual diseases and gonorrhea0.10
Erythrophleum ivorense
A. Chev
FabaceaeEloneBDecoctionDermal and oral routeEczema, burns, and ulcers0.45
UnidentifiedUnidentifiedNgôneBMacerationOral and dermal routeEczema, wounds, and gonorrhea0.15
Parkia bicolor A. ChevMimosaceaeEssangBInfusionRectal and oral routeHemorrhoids and chronic coughs0.10
Chlorophora exceisa
(Welw) Benth.
MoraceaeAbang Elé’eBMacerationOral routeFever and diarrhea0.20
Guibourtia tessmannii
(Harms) J. Leonard
FabaceaeOvengBLInfusionOral routeSexual weaknesses and sexually transmitted diseases0.40
UnidentifiedUnidentifiedAbèeBLPowderRectal routeFemale infertility and fallopian tube obstruction in women0.15
Bobgunnia fistuloides
(Harms) J.H. Kirkbr. & Wiersema
MimosaceaeAkok Elé’eBMacerationAnal routeHemorrhoids0.20
UnidentifiedUnidentifiedAkora Elé’eBLMacerationOral routeBody and mouth odor due to bacteria0.10
Cylicodiscus gabunensis
Harms
MimosaceaeEdoumBPowderOral routeSexual infections0.25
Ceiba pentandra
(L.) Gaertn.
MalvaceaeDoumBDecoctionOral routeClogged trumpets0.15
Note: BL, the abbreviation of Bark and Leaves; B, the abbreviation of Bark; a, indicates that the language of the investigation is Fang.
Table 4. Compounds putatively identified in the molecular network obtained from the crude extract of Erismadelphus exsul leaves.
Table 4. Compounds putatively identified in the molecular network obtained from the crude extract of Erismadelphus exsul leaves.
Precursor m/zExact MassMolecular FormulaAdductCosine ScoreCompound NameSuperclass
433.110432.106C21H20O10[M + H]+0.94VitexinFlavonoids
595.168594.163C27H30O15[M + H]+0.90Kaempferol 3-neohesperidosideFlavonoids
665.317663.647C34H48O13[M + H]+0.87Sarmentoside BSteroids
269.081268.640C16H12O4[M + H]+0.86FormononetinIsoflavonoids
801.445801.444C45H57N3O9[M + NH4]+0.85BeauvericinOligopeptides
433.222433.231C24H32O7[M + H]+0.83GrandisinLignans
449.108449.111C21H20O11[M + H]+0.82IsoorientinFlavonoids
593.274593.27C35H36N4O5[M + H]+0.82Pheophorbide ATryptophan alkaloids
445.212444.205C27H28N2O4[M + H]+0.81AsperglaucideSmall peptides
283.091282.089C17H14O4[M + H]+0.814′,7-DimethoxyisoflavoneIsoflavonoids
327.229304.240C20H32O2[M + Na]+0.80DrostanoloneSteroids
355.202354.194C21H26N2O3[M + H]+0.73ErvatamineTryptophan alkaloids
337.060314.079C17H14O6[M + Na]+0.73Salvianolic acid FStilbenoids/Lignans
333.029334.022C14H14Cl2O5[M + H]+0.733-(3,3-dichloro-2-hydroxypropyl)-6,8-dimethoxyisochromen-1-oneCoumarins
255.065255.070C15H10O4[M + H]+0.705,3′-DihydroxyflavoneFlavonoids
438.228396.194C24H28O5[M + ACN + H]+0.84(E)-3-(4-methoxyphenyl)-1-[2,4,6-trimethoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-oneFlavonoids
507.019507.232C32H30N2O4[M + H]+0.94AsperphenamateSmall peptides
402.213403.207C25H26N2O3[M + H]+0.84AurantiamideSmall peptides
Table 5. Antioxidant properties of the crude extract (Ce) and fractions (F1–F5) of Erismadelphus exsul leaves.
Table 5. Antioxidant properties of the crude extract (Ce) and fractions (F1–F5) of Erismadelphus exsul leaves.
SampleFRAP (µM TE/g DW)DPPH (µM TE/g DW)
EE EtOH LCe1023.09 ± 11.5340.56 ± 1.31
EE EtOH LF1200.28 ± 9.1548.54 ± 2.72
EE EtOH LF2112.82 ± 4.5546.18 ± 6.34
EE EtOH LF3231.15 ± 72.77180.43 ± 24.03
EE EtOH LF4510.08 ± 2.65123.88 ± 39.61
EE EtOH LF5482.72 ± 31.27209.05 ± 5.57
Ascorbic Acid631.99 ± 39.081261.79 ± 150.68
The results are expressed as mean ± standard deviation (S.D.); EE = Erismadelphus exsul and DW = Dry weight. LCe = Leaves crude extract, F = Fractions, L = Leaves, and TE = Trolox equivalent.
Table 6. Inhibition zone diameters (IZD) of crude extract and ethanolic fractions of Erismadelphus exsul.
Table 6. Inhibition zone diameters (IZD) of crude extract and ethanolic fractions of Erismadelphus exsul.
Inhibition Zone Diameter (IZD, mm)
SampleBacterial Strains
E. coli ATCC 25922E. coli ATCC 8739K. p MDRS. entericaE. coli ESBL
EE EtOH BCe11.67 ± 0.4721.33 ± 0.4712.33 ± 0.4713.33 ± 0.4714.33 ± 0.47
EE EtOH BF1NaNaNa24.67 ± 0.47Na
EE EtOH BF210 ± 0.0011 ± 0.0013.33 ± 0.4712 ± 0.009 ± 0.00
EE EtOH BF311 ± 0.0011.33 ± 0.479 ± 0.009.33 ± 0.479.33 ± 0.94
EE EtOH BF420 ± 1.4118 ± 0.9422.67 ± 0.479 ± 0.0010 ± 0.00
EE EtOH BF510 ± 0.82Na11.33 ± 0.9413 ± 0.0012.67 ± 0.47
EE EtOH LCe12 ± 0.8217 ± 0.4711.33 ± 0.4717.33 ± 0.4720.33 ± 0.94
EE EtOH LF1Na10 ± 0.0022.33 ± 0.4710.33 ± 0.9420.67 ± 0.44
EE EtOH LF213.33 ± 0.479.67 ± 0.4712.33 ± 0.829.00 ± 0.0014.67 ± 0.44
EE EtOH LF39.00 ± 0.00NaNaNa8.00 ± 0.00
EE EtOH LF412 ± 0.00Na8.33 ± 0.47NaNa
EE EtOH LF514.33 ± 0.4717.67 ± 1.7022 ± 0.0017.67 ± 0.4727.67 ± 0.47
Ticarcillin19.33 ± 0.4721.33 ± 0.4720 ± 0.0020 ± 0.00Na
Gentamicin30 ± 0.0023 ± 0.0021 ± 0.0022.33 ± 0.4722 ± 0.00
TetracyclineNaNa12 ± 0.00NaNa
1% DMSONaNaNaNaNa
EE = Erismadelphus exsul; BCe = Bark crude extract; LCe = Leaves crude extract; E. coli = Escherichia coli; K. p MDR = Klebsiella pneumoniae multi-drug-resistant; S. enterica = Salmonella enterica; E. coli ESBL = Escherichia coli extended-spectrum beta-lactamase-producing; EtOH = ethanolic; F = fraction; Na = not active.
Table 7. Minimum inhibitory concentrations (MICs) and bactericidal concentrations (MBCs) of crude extract and ethanolic fractions of Erismadelphus exsul.
Table 7. Minimum inhibitory concentrations (MICs) and bactericidal concentrations (MBCs) of crude extract and ethanolic fractions of Erismadelphus exsul.
MIC and MBC (mg/mL)
SampleE. coli ATCC 25922E. coli ATCC 8739K. p MDRS. entericaE. coli ESBL
MICMBCMICMBCMICMBCMICMBCMICMBC
EE EtOH BCe1.2551.252.50.6250.6251.252.5
EE EtOH BF1NtNtNtNtNtNt1.251.25NtNt
EE EtOH BF21.2551.2550.622.50.622.52.55
EE EtOH BF32.552.5>55>52.5>52.55
EE EtOH BF41.252.50.621.251.252.51.252.50.622.5
EE EtOH BF52.5>5NtNt2.5>51.252.51.252.5
EE EtOH LCe0.6251.252.50.6251.252.51.252.5
EE EtOH LF1NtNtNtNt1.252.50.6251.251.25
EE EtOH LF21.252.50.622.52.5>50.3150.622.5
EE EtOH LF32.5>5NtNtNtNtNtNt2.5>5
EE EtOH LF42.50.62NtNt0.625NtNtNtNt
EE EtOH LF51.251.251.251.251.251.251.251.251.251.25
EE = Erismadelphus exsul; BCe = Bark crude extract; LCe = Leaves crude extract; E. coli = Escherichia coli; K. p MDR = Klebsiella pneumoniae multi-drug-resistant; S. enterica = Salmonella enterica; E. coli ESBL = Escherichia coli extended-spectrum beta-lactamase-producing; EtOH = ethanolic; F = fraction; Nt = not tested.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mintsa, M.E.; Obiang, C.S.; Choque, E.; Dussert, E.; Ravallec, R.; Ondo, J.-P.; Belloncle, C.; Kumulungui, B.S.; Mesnard, F. Antimicrobial Plants Used by Fang Populations and Phytochemical Profiling of Erismadelphus exsul. Molecules 2024, 29, 3503. https://doi.org/10.3390/molecules29153503

AMA Style

Mintsa ME, Obiang CS, Choque E, Dussert E, Ravallec R, Ondo J-P, Belloncle C, Kumulungui BS, Mesnard F. Antimicrobial Plants Used by Fang Populations and Phytochemical Profiling of Erismadelphus exsul. Molecules. 2024; 29(15):3503. https://doi.org/10.3390/molecules29153503

Chicago/Turabian Style

Mintsa, Morel Essono, Cédric Sima Obiang, Elodie Choque, Elodie Dussert, Rozenn Ravallec, Joseph-Privat Ondo, Christophe Belloncle, Brice Serge Kumulungui, and François Mesnard. 2024. "Antimicrobial Plants Used by Fang Populations and Phytochemical Profiling of Erismadelphus exsul" Molecules 29, no. 15: 3503. https://doi.org/10.3390/molecules29153503

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop